191 related articles for article (PubMed ID: 22077226)
1. Astragalus polysaccharides enhance the humoral and cellular immune responses of hepatitis B surface antigen vaccination through inhibiting the expression of transforming growth factor β and the frequency of regulatory T cells.
Du X; Chen X; Zhao B; Lv Y; Zhang H; Liu H; Chen Z; Chen Y; Zeng X
FEMS Immunol Med Microbiol; 2011 Nov; 63(2):228-35. PubMed ID: 22077226
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of humoral and cellular responses to HBsAg DNA vaccination by immunization with praziquantel through inhibition TGF-beta/Smad2,3 signaling.
Zou Q; Zhong Y; Su H; Kang Y; Jin J; Liu Q; Geng S; Zhao G; Wang B
Vaccine; 2010 Feb; 28(8):2032-8. PubMed ID: 20188260
[TBL] [Abstract][Full Text] [Related]
3. Astragalus polysaccharides enhance immune responses of HBV DNA vaccination via promoting the dendritic cell maturation and suppressing Treg frequency in mice.
Du X; Zhao B; Li J; Cao X; Diao M; Feng H; Chen X; Chen Z; Zeng X
Int Immunopharmacol; 2012 Dec; 14(4):463-70. PubMed ID: 23006659
[TBL] [Abstract][Full Text] [Related]
4. Cimetidine enhances immune response of HBV DNA vaccination via impairment of the regulatory function of regulatory T cells.
Wang J; Su B; Ding Z; Du X; Wang B
Biochem Biophys Res Commun; 2008 Aug; 372(3):491-6. PubMed ID: 18502198
[TBL] [Abstract][Full Text] [Related]
5. Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice.
Wang S; Qiu L; Liu G; Li Y; Zhang X; Jin W; Gao GF; Kong X; Meng S
Vaccine; 2011 Aug; 29(37):6342-51. PubMed ID: 21600951
[TBL] [Abstract][Full Text] [Related]
6. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
Wild J; Grusby MJ; Schirmbeck R; Reimann J
J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting effect of Astragalus polysaccharides on the functions of CD4+CD25 highTreg cells in the tumor microenvironment of human hepatocellular carcinoma.
Li Q; Bao JM; Li XL; Zhang T; Shen XH
Chin Med J (Engl); 2012 Mar; 125(5):786-93. PubMed ID: 22490576
[TBL] [Abstract][Full Text] [Related]
8. Sulfated radix Cyathulae officinalis polysaccharides act as adjuvant via promoting the dendritic cell maturation and suppressing Treg frequency.
Feng H; Fan J; Du X; Song Z; Wang Z; Han X; Zhao B; Liu J
Immunol Invest; 2015; 44(3):288-308. PubMed ID: 25775390
[TBL] [Abstract][Full Text] [Related]
9. The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination.
Du X; Zheng G; Jin H; Kang Y; Wang J; Xiao C; Zhang S; Zhao L; Chen A; Wang B
J Gene Med; 2007 Feb; 9(2):136-46. PubMed ID: 17310492
[TBL] [Abstract][Full Text] [Related]
10. Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses.
Schiött A; Larsson K; Manniche S; Kalliomäki S; Heydenreich AV; Dalsgaard K; Kirkby N
Int J Pharm; 2011 Jul; 414(1-2):312-20. PubMed ID: 21601626
[TBL] [Abstract][Full Text] [Related]
11. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z
Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093
[TBL] [Abstract][Full Text] [Related]
12. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
[TBL] [Abstract][Full Text] [Related]
13. [Cellular immune responses of recombinant hepatitis B (rHB) vaccine and HBsAG derived from Hansenula polymorpha cells].
Hu ZY; He P; Zhang R; Fang X; Zhu FC; Qiu SH; Li HM; Wang H; Liang ZL; Zhuang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jul; 29(7):706-11. PubMed ID: 19031766
[TBL] [Abstract][Full Text] [Related]
14. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen.
Song ES; Park SA; Kim SH; Cho YJ; Ahn BY; Ahn BC; Lee NG
FEMS Immunol Med Microbiol; 2007 Dec; 51(3):496-504. PubMed ID: 17877731
[TBL] [Abstract][Full Text] [Related]
16. Synergistic and additive effects of cimetidine and levamisole on cellular immune responses to hepatitis B virus DNA vaccine in mice.
Niu X; Yang Y; Wang J
Scand J Immunol; 2013 Feb; 77(2):84-91. PubMed ID: 23298196
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination.
Bauer T; Jilg W
Vaccine; 2006 Jan; 24(5):572-7. PubMed ID: 16171909
[TBL] [Abstract][Full Text] [Related]
18. Augmented humoral and cellular immune response of hepatitis B virus DNA vaccine by micro-needle vaccination using Flt3L as an adjuvant.
Zhou Q; Wang F; Yang F; Wang Y; Zhang X; Sun S
Vaccine; 2010 Feb; 28(5):1357-62. PubMed ID: 19932674
[TBL] [Abstract][Full Text] [Related]
19. A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice.
Buchmann P; Dembek C; Kuklick L; Jäger C; Tedjokusumo R; von Freyend MJ; Drebber U; Janowicz Z; Melber K; Protzer U
Vaccine; 2013 Feb; 31(8):1197-203. PubMed ID: 23306359
[TBL] [Abstract][Full Text] [Related]
20. Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults.
Vandepapelière P; Rehermann B; Koutsoukos M; Moris P; Garçon N; Wettendorff M; Leroux-Roels G
Vaccine; 2005 Apr; 23(20):2591-601. PubMed ID: 15780441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
